(Q34546591)

PubMed publication ID

2 August 2017

1 reference

title

A new look at the 5alpha-reductase inhibitor finasteride (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

Matthew M Ford

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

Kristine M. Wiren

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

author name string

Deborah A Finn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

Amy S Beadles-Bohling

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

Katherine R Gililland

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

Rebecca E Gorin-Meyer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

publication date

1 January 2006

1 reference

PubMed publication ID

16834758

CNS Neuroscience & Therapeutics

2 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

page(s)

53-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

Depression circumstantially related to the administration of finasteride for androgenetic alopecia

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Inhibition of rat alpha-reductases by finasteride: evidence for isozyme differences in the mechanism of inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Low-dose (2.5 mg/day) finasteride treatment in hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Neurosteroids: endogenous regulators of the GABA(A) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Chromosomal loci influencing chronic alcohol withdrawal severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Anxiolytic effects of the neuroactive steroid pregnanolone (3 alpha-OH-5 beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Emerging diversities in the mechanism of action of steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Chronic intermittent ethanol (CIE) administration in rats decreases levels of neurosteroids in hippocampus, accompanied by altered behavioral responses to neurosteroids and memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Steroid metabolism in the mammalian brain: 5alpha-reduction and aromatization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Clinical application of 5alpha-reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Drug or symptom-induced depression in men treated with alpha 1-blockers for benign prostatic hyperplasia? A nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Genetic correlations with ethanol withdrawal severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

A conceptualization of integrated actions of ethanol contributing to its GABAmimetic profile: a commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Progesterone enhances ethanol-induced modulation of mesocortical dopamine neurons: antagonism by finasteride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Testosterone's analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Interaction of chronic ethanol exposure and finasteride: sex and strain differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Sex differences in the effect of ethanol injection and consumption on brain allopregnanolone levels in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Modulation of GABA(A) receptor gene expression by allopregnanolone and ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL/6J mice: potential role of endogenous neurosteroids?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Allopregnanolone levels and symptom improvement in severe premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

The role of neurosteroids and nongenomic effects of progestins in the ventral tegmental area in mediating sexual receptivity of rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3 alpha,5 alpha-THP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

The neurosteroids, progesterone and 3alpha,5alpha-THP, enhance sexual motivation, receptivity, and proceptivity in female rats

21 January 2018

2 references

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

21 January 2018

12 December 2020

Androgenic neurosteroids: anti-seizure effects in an animal model of epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Progesterone's 5 alpha-reduced metabolite, 3 alpha,5 alpha-THP, mediates lateral displacement of hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Finasteride blocks the reduction in ictal activity produced by exogenous estrous cyclicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Progestins' rapid facilitation of lordosis when applied to the ventral tegmentum corresponds to efficacy at enhancing GABA(A)receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Ventral tegmental area infusions of inhibitors of the biosynthesis and metabolism of 3alpha,5alpha-THP attenuate lordosis of hormone-primed and behavioural oestrous rats and hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Hippocampal 3alpha,5alpha-THP may alter depressive behavior of pregnant and lactating rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Allopregnanolone does not influence ethanol-induced conditioned place preference in DBA/2J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Effects of finasteride on chronic and acute ethanol withdrawal severity in the WSP and WSR selected lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Finasteride: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

The role of GABA(A) receptors in the acute and chronic effects of ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

5 alpha-reductase inhibitors, chemical and clinical models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Modulation of the GABA receptor complex by a steroid anaesthetic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Seizure exacerbation associated with inhibition of progesterone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Three patterns of catamenial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Altered profiles of serum neuroactive steroids in premenopausal women treated for alcohol addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Reinstatement of serum pregnanolone isomers and progesterone during alcohol detoxification therapy in premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Reversal of caffeine-induced anxiety by neurosteroid 3-alpha-hydroxy-5-alpha-pregnane-20-one in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Anticonvulsant activity of androsterone and etiocholanolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Pharmacological options in the treatment of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Ethanol-induced elevation of 3 alpha-hydroxy-5 alpha-pregnan-20-one does not modulate motor incoordination in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Role of progesterone and other neuroactive steroids in anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Inhibition of brain 5 alpha-reductase in pregnant rats: effects on enzymatic and behavioral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Finasteride in the treatment of alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Non-genomic and genomic effects of steroids on neural activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Biosynthesis of neurosteroids and regulation of their synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Neurosteroids mediate pharmacological effects of ethanol: a new mechanism of ethanol action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Inhibition of human steroid 5alpha reductases type I and II by 6-aza-steroids: structural determinants of one-step vs two-step mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Evaluation and treatment of male and female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Role of neurosteroids in catamenial epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Anxiolytic activity of progesterone in progesterone receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Attenuating 5alpha-pregnane-3alpha-ol-20-one formation in the hippocampus of female rats increases pentylenetetrazole-induced seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Effects of antidepressant treatment on neuroactive steroids in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Brain steroidogenesis mediates ethanol modulation of GABAA receptor activity in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

The clinical development of a 5α-reductase inhibitor, finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Alcohol intoxication increases allopregnanolone levels in male adolescent humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Relative safety and efficacy of finasteride for treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Finasteride inhibits the progesterone-induced spike-wave discharges in a genetic model of absence epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Differences in affective behaviors and hippocampal allopregnanolone levels in adult rats of lines selectively bred for infantile vocalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00053.X

Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans

21 January 2018

1 reference

12 December 2020

Neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol.

1 reference

12 December 2020

A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism

1 reference

12 December 2020

Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy.

1 reference

12 December 2020

Anticonvulsive effect of swim stress in mice

1 reference

12 December 2020

Anti-sense oligonucleotides, for progestin receptors in the VMH and glutamic acid decarboxylase in the VTA, attenuate progesterone-induced lordosis in hamsters and rats

1 reference

12 December 2020

Progesterone and 3alpha,5alpha-THP enhance sexual receptivity in mice

1 reference

12 December 2020

Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility.

1 reference

12 December 2020

Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal.

1 reference

12 December 2020

Alcohol Intoxication Increases Allopregnanolone Levels in Female Adolescent Humans

1 reference

12 December 2020

Four-amino acid segment in steroid 5 alpha-reductase 1 confers sensitivity to finasteride, a competitive inhibitor

1 reference

12 December 2020

1 reference

12 December 2020

Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans

1 reference

12 December 2020

Finasteride, a Type 2 5alpha-reductase inhibitor, in the treatment of men with androgenetic alopecia

1 reference

12 December 2020

Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: a possible model of premenstrual dysphoric disorder

1 reference

12 December 2020

Inhibiting 5alpha-reductase in the amygdala attenuates antianxiety and antidepressive behavior of naturally receptive and hormone-primed ovariectomized rats

1 reference

12 December 2020

Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems

1 reference

12 December 2020

Pharmacokinetics and biochemical efficacy after single and multiple oral administration of N-(2-methyl-2-propyl)-3-oxo-4-aza-5 alpha-androst-1-ene-17 beta-carboxamide, a new type of specific competitive inhibitor of testosterone 5 alpha-reductase, i

1 reference

12 December 2020

Effect of Finasteride, a 5α-Reductase Inhibitor on Prostate Tissue Androgens and Prostate-Specific Antigen*

1 reference

12 December 2020

Sex differences in the effect of finasteride on acute ethanol withdrawal severity in C57BL/6J and DBA/2J mice.

1 reference

12 December 2020

Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers

1 reference

12 December 2020

Effect of MK-906, a specific 5 alpha-reductase inhibitor, on serum androgens and androgen conjugates in normal men

1 reference

12 December 2020

Ethanol withdrawal in mice bred to be genetically prone or resistant to ethanol withdrawal seizures.

1 reference

12 December 2020

Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy

1 reference

12 December 2020

Hormones and Sexual Behavior

1 reference

12 December 2020

Catamenial epilepsy: a review

1 reference

12 December 2020

Effects of gonadal hormones on pacing of sexual contacts by female rats

1 reference

12 December 2020

The effects of estrogen and progesterone on female rat proceptive behavior

1 reference

12 December 2020

Effects of Long-Term Antiepileptic Therapy on the Catabolism of Testosterone

1 reference

12 December 2020

Anxiolytic Effect of Progesterone is Mediated by the Neurosteroid Allopregnanolone at Brain GABAA Receptors

1 reference

12 December 2020

Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism

1 reference

12 December 2020

Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression

1 reference

12 December 2020

Finasteride: the first 5 alpha-reductase inhibitor.

1 reference

12 December 2020

The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness

1 reference

12 December 2020

1 reference

12 December 2020

A putative receptor for neurosteroids on the GABAA receptor complex: the pharmacological properties and therapeutic potential of epalons

1 reference

12 December 2020

Metabolism of anabolic androgenic steroids

1 reference

12 December 2020

Effects of finasteride on health-related quality of life in men with symptomatic benign prostatic hyperplasia. Finasteride Study Group.

1 reference

12 December 2020

Synthesis of 5,6,6-[2H3]finasteride and quantitative determination of finasteride in human plasma at picogram level by an isotope-dilution mass spectrometric method

1 reference

12 December 2020

Marked decrease of plasma neuroactive steroids during alcohol withdrawal.

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of finasteride

1 reference

12 December 2020

LY191704 inhibits type I steroid 5 alpha-reductase in human scalp

1 reference

12 December 2020

5alpha-reductase inhibitors.

1 reference

12 December 2020

Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety.

1 reference

12 December 2020

Provisional mapping of quantitative trait loci for chronic ethanol withdrawal severity in BXD recombinant inbred mice

1 reference

12 December 2020

Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice.

1 reference

12 December 2020

10.1111/J.1527-3458.2006.00053.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741762&resulttype=core&format=json

12 May 2020

PubMed publication ID

16834758

1 reference